Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Cough, Fatigue, Muscle rupture, Respiratory syncytial virus infection
Clinical narrative: tore some chest and back muscles from severe coughing; Cough; weak; Very exhausted; did not know if it was RSV not diagnosed as such; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Nov2022 as dose 5 (booster), single (Lot number: EL8916) at the age of 73 years for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "Depression" (unspecified if ongoing); "Stomach acid" (unspecified if ongoing); "Type 2 diabetes" (unspecified if ongoing); "hearing loss" (unspecified if ongoing). Concomitant medication(s) included: ENALAPRIL oral taken for hypertension, start date: 2003 (ongoing); IMIPRAMINE oral taken for depression, start date: 2003 (ongoing); PANTOPRAZOL [PANTOPRAZOLE] oral taken for dyspepsia (ongoing); METFORMIN oral taken for type 2 diabetes mellitus, start date: 2021, stop date: Mar2023. Vaccination history included: BNT162b2 (dose 1, administered intramuscularly in the left arm, Lot number: ER8727), administration date: 23Mar2021, when the patient was 71-year-old, for Covid-19 immunization; BNT162b2 (dose 2, administered intramuscularly in the arm, Lot number: ER8731), administration date: 13Apr2021, when the patient was 71-year-old, for Covid-19 immunization; BNT162b2 (dose 3 (booster), administered intramuscularly in the arm, Lot number: FG3527), administration date: 22Nov2021, when the patient was 72-year-old, for Covid-19 immunization; BNT162b2 (dose 4, administered intramuscularly in the arm, Lot number: FK9894), administration date: 25Apr2022, when the patient was 72-year-old, for Covid-19 immunization, reaction(s): "tore some chest and back muscles from severe coughing", "Very exhausted", "weak", "did not know if it was RSV not diagnosed as such". The following information was reported: MUSCLE RUPTURE (medically significant), outcome "unknown", described as "tore some chest and back muscles from severe coughing"; COUGH (non-serious), outcome "recovered"; ASTHENIA (non-serious), outcome "unknown", described as "weak"; FATIGUE (non-serious), outcome "unknown", described as "Very exhausted"; RESPIRATORY SYNCYTIAL VIRUS INFECTION (non-serious), outcome "unknown", described as "did not know if it was RSV not diagnosed as such". Clinical course: Patient developed a serious cough in mid-Oct2022 so severe she tore some chest + back muscles from severe coughing. She had 2 years-no pneumonia. Very exhausted + weak from this. She did not know if it was RSV not diagnosed as such. She talked to friends+relatives (illegible) who described identical cough, relentless. She had 5 Pfizer vaccinations/boosters. On 01Jan2023, she got COVID+ was prescribed Paxlovid, and after 3 days on, the cough she had for 2.5 months was gone. The COVID was light, mostly fatigue for several weeks.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300039609 same patient, different vaccine dose/event;